NDC 69097-852

Naproxen

Naproxen

Naproxen is a Oral Tablet, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Cipla Usa Inc.. The primary component is Naproxen.

Product ID69097-852_d582dc4b-42a6-45ed-84eb-d701a68592c0
NDC69097-852
Product TypeHuman Prescription Drug
Proprietary NameNaproxen
Generic NameNaproxen
Dosage FormTablet, Delayed Release
Route of AdministrationORAL
Marketing Start Date2016-07-05
Marketing CategoryANDA / ANDA
Application NumberANDA091432
Labeler NameCipla USA Inc.
Substance NameNAPROXEN
Active Ingredient Strength500 mg/1
Pharm ClassesCyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 69097-852-07

100 TABLET, DELAYED RELEASE in 1 BOTTLE (69097-852-07)
Marketing Start Date2016-07-05
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 69097-852-07 [69097085207]

Naproxen TABLET, DELAYED RELEASE
Marketing CategoryANDA
Application NumberANDA091432
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2016-07-05

NDC 69097-852-12 [69097085212]

Naproxen TABLET, DELAYED RELEASE
Marketing CategoryANDA
Application NumberANDA091432
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-07-05

Drug Details

Active Ingredients

IngredientStrength
NAPROXEN500 mg/1

OpenFDA Data

SPL SET ID:e06c2b43-9882-442e-8413-10d9a33aecb9
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 603103
  • 311915
  • PHarm Class EPC
  • Nonsteroidal Anti-inflammatory Drug [EPC]
  • UPC Code
  • 0369097852078
  • 0369097851071
  • NUI Code
  • N0000000160
  • N0000175722
  • N0000175721
  • Pharmacological Class

    • Cyclooxygenase Inhibitors [MoA]
    • Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient]
    • Nonsteroidal Anti-inflammatory Drug [EPC]

    Medicade Reported Pricing

    69097085207 NAPROXEN DR 500 MG TABLET

    Pricing Unit: EA | Drug Type: